Suppr超能文献

联合 iStent 小梁微旁路支架植入术和超声乳化术治疗合并开角型青光眼和白内障:一项长期研究。

Combined iStent trabecular micro-bypass stent implantation and phacoemulsification for coexistent open-angle glaucoma and cataract: a long-term study.

机构信息

Servicio de Oftalmología, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

出版信息

Br J Ophthalmol. 2012 May;96(5):645-9. doi: 10.1136/bjophthalmol-2011-300218. Epub 2012 Jan 23.

Abstract

AIMS

To evaluate the long-term efficacy and safety of combined cataract surgery and Glaukos iStent implantation for coexistent open-angle glaucoma and cataract.

METHODS

Prospective, non-comparative, uncontrolled, non-randomised, interventional case series study. Subjects older than 18 years with coexistent uncontrolled mild or moderate open-angle glaucoma (including pseudoexfoliative and pigmentary) and cataract underwent phacoemulsification and intraocular lens implantation along with ab-interno gonioscopically guided implantation of one Glaukos iStent. The variables recorded during a minimum of 3 years of follow-up were: intraocular pressure (IOP), number of antiglaucoma medications and best-corrected visual acuity.

RESULTS

The 19 patients enrolled were 58-88 years old (mean age 74.6±8.44 years). Mean follow-up was 53.68±9.26 months. Mean IOP was reduced from 19.42±1.89 mm Hg to 16.26±4.23 mm Hg (p=0.002) at the end of follow up, indicating a 16.33% decrease in IOP. The mean number of pressure-lowering medications used by the patients fell from 1.32±0.48 to 0.84±0.89 (p=0.046). In 42% of patients, no antiglaucoma medications were used at the end of follow-up. Mean best-corrected visual acuity significantly improved from 0.29±0.13 to 0.62±0.3 (p<0.001). No complications of surgery were observed.

CONCLUSION

Combined cataract surgery and Glaukos iStent implantation seems to be an effective and safe procedure to treat coexistent open-angle glaucoma and cataract.

摘要

目的

评估白内障超声乳化吸除联合 Glaukos iStent 植入术治疗开角型青光眼合并白内障的长期疗效和安全性。

方法

前瞻性、非对照、非随机、干预性病例系列研究。纳入年龄大于 18 岁、合并未经控制的轻中度开角型青光眼(包括原发性开角型青光眼和色素性青光眼)和白内障的患者,行白内障超声乳化吸除联合人工晶状体植入术,并在内路式房角镜引导下植入 Glaukos iStent。术后至少随访 3 年,记录眼压(IOP)、降眼压药物的使用数量和最佳矫正视力。

结果

19 例患者年龄 58-88 岁(平均年龄 74.6±8.44 岁)。平均随访时间为 53.68±9.26 个月。术后 IOP 由 19.42±1.89mmHg 降至 16.26±4.23mmHg(p=0.002),降低了 16.33%。患者平均使用的降眼压药物数量从 1.32±0.48 降至 0.84±0.89(p=0.046)。在随访结束时,42%的患者无需使用任何降眼压药物。平均最佳矫正视力从 0.29±0.13 提高至 0.62±0.3(p<0.001)。术后无手术相关并发症发生。

结论

白内障超声乳化吸除联合 Glaukos iStent 植入术治疗开角型青光眼合并白内障是一种有效且安全的方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验